An ascending single dose study of the safety and pharmacokinetics of IMA-638 administered to healthy Japanese subjects

Trial Profile

An ascending single dose study of the safety and pharmacokinetics of IMA-638 administered to healthy Japanese subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Mar 2014

At a glance

  • Drugs Anrukinzumab (Primary)
  • Indications Asthma; Ulcerative colitis
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Jul 2007 Status changed from recruiting to completed.
    • 08 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top